San Francisco, CA, United States of America

Esfir Goldberg

This inventor holds 1 USPTO granted patent. Top assignee: Biomedix, Inc.. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 403(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Esfir Goldberg - Innovator in Glucose Biosensing Technology

Introduction

Esfir Goldberg is a prominent inventor based in San Francisco, CA, known for her groundbreaking work in the field of biosensing technology. She has made significant contributions to the development of highly sensitive glucose biosensors, which are crucial for diabetes management and monitoring.

Latest Patents

Esfir holds a patent for a "Highly sensitive amperometric bi-mediator-based glucose biosensor." This innovative sensor features a face-to-face sandwich configuration that includes a sensing electrode strip with a first redox mediator and a reference electrode strip in contact with a reagent strip containing a second redox mediator. The design allows for the direct assay of glucose in whole blood without the need for sample preparation, making it a valuable tool in medical diagnostics.

Career Highlights

Esfir Goldberg is associated with Biomedix, Inc., where she continues to advance her research and development efforts. Her work has led to the creation of a sensor that utilizes a whole blood separation membrane to filter red blood cells, enhancing the accuracy and efficiency of glucose measurements.

Collaborations

Esfir collaborates with notable colleagues, including Dingli Guo and Paul Shieh, who contribute to her innovative projects and research initiatives.

Conclusion

Esfir Goldberg's contributions to glucose biosensing technology exemplify her dedication to improving healthcare solutions. Her innovative patent and collaborative efforts position her as a key figure in the field of medical diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…